Wenyu Liu

RETRACTION: Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial

Xiaofei Zhu, Yangsen Cao, Wenyu Liu et al. · The Lancet Oncology · 2021 · 72 citations

Medicine, Oncology, Surgery +12

Rapamycin Protects Sepsis-Induced Cognitive Impairment in Mouse Hippocampus by Enhancing Autophagy

Wenyu Liu, Jianan Guo, Jie Mu et al. · Cellular and Molecular Neurobiology · 2016 · 52 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study

Jin Lu, Weijun Fu, Wei Li et al. · Clinical Lymphoma Myeloma & Leukemia · 2021 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Insights on the binding mechanism between specified aldehydes and flaxseed protein using multispectral image and molecular docking

Lingxia Xu, Yilai Wan, Xiaoxiao Liu et al. · Food Chemistry · 2023 · 34 citations

Life Sciences, Biochemistry, Molecular Biology +14

Identification and functional analysis of heterogeneous FOXP3+ Treg cell subpopulations in human pancreatic ductal adenocarcinoma

Gang Yi, Shiwei Guo, Wenyu Liu et al. · Science Bulletin · 2018 · 27 citations

Medicine, Immunology, Oncology +11